Test ID: MAPTM
MAPT Gene, Sequence Analysis, 7 Exon Screening Panel
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
87924
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Conditional
Useful For Suggests clinical disorders or settings where the test may be helpful
Aiding in the diagnosis of frontotemporal dementia, progressive supranuclear palsy, corticobasal degeneration, and dementia with epilepsy
Distinguishing the diagnosis of frontotemporal dementia from other dementias, including Alzheimer dementia
Identifying individuals who are at risk of frontotemporal dementia
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Polymerase Chain Reaction (PCR)/DNA Sequencing Analysis
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
MAPT Screening Sequence Analysis
Aliases Lists additional common names for a test, as an aid in searching
Frontotemporal dementia
Microtubule-associated protein tau
Pick's disease
Tau
Tauopathy
Microtubule-associated protein tau
Pick's disease
Tau
Tauopathy
External
link
PDF
document
Excel
document
Word
document